Filippatos, F.; Tatsi, E.-B.; Dourdouna, M.-M.; Zoumakis, E.; Margeli, A.; Syriopoulou, V.; Michos, A.
SARS-CoV-2 Seroepidemiology and Antibody Levels in Children during BA.5 Predominance Period. Diagnostics 2024, 14, 1039.
https://doi.org/10.3390/diagnostics14101039
AMA Style
Filippatos F, Tatsi E-B, Dourdouna M-M, Zoumakis E, Margeli A, Syriopoulou V, Michos A.
SARS-CoV-2 Seroepidemiology and Antibody Levels in Children during BA.5 Predominance Period. Diagnostics. 2024; 14(10):1039.
https://doi.org/10.3390/diagnostics14101039
Chicago/Turabian Style
Filippatos, Filippos, Elizabeth-Barbara Tatsi, Maria-Myrto Dourdouna, Emmanouil Zoumakis, Alexandra Margeli, Vasiliki Syriopoulou, and Athanasios Michos.
2024. "SARS-CoV-2 Seroepidemiology and Antibody Levels in Children during BA.5 Predominance Period" Diagnostics 14, no. 10: 1039.
https://doi.org/10.3390/diagnostics14101039
APA Style
Filippatos, F., Tatsi, E. -B., Dourdouna, M. -M., Zoumakis, E., Margeli, A., Syriopoulou, V., & Michos, A.
(2024). SARS-CoV-2 Seroepidemiology and Antibody Levels in Children during BA.5 Predominance Period. Diagnostics, 14(10), 1039.
https://doi.org/10.3390/diagnostics14101039